Fresh2 Group (FRES) Competitors $1.01 -0.01 (-0.98%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsShort InterestTrends FRES vs. ACON, MDXH, LH, NTRA, DGX, EXAS, RDNT, GH, VCYT, and FTREShould you be buying Fresh2 Group stock or one of its competitors? The main competitors of Fresh2 Group include Aclarion (ACON), MDxHealth (MDXH), Laboratory Co. of America (LH), Natera (NTRA), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), Guardant Health (GH), Veracyte (VCYT), and Fortrea (FTRE). These companies are all part of the "medical laboratories" industry. Fresh2 Group vs. Aclarion MDxHealth Laboratory Co. of America Natera Quest Diagnostics Exact Sciences RadNet Guardant Health Veracyte Fortrea Aclarion (NASDAQ:ACON) and Fresh2 Group (NASDAQ:FRES) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability. Do institutionals & insiders have more ownership in ACON or FRES? 7.5% of Aclarion shares are owned by institutional investors. Comparatively, 0.5% of Fresh2 Group shares are owned by institutional investors. 1.7% of Aclarion shares are owned by company insiders. Comparatively, 26.2% of Fresh2 Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts prefer ACON or FRES? Aclarion presently has a consensus price target of $1.50, indicating a potential upside of 818.55%. Given Aclarion's higher probable upside, equities research analysts clearly believe Aclarion is more favorable than Fresh2 Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Fresh2 Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has stronger valuation and earnings, ACON or FRES? Aclarion has higher earnings, but lower revenue than Fresh2 Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$53.95K30.70-$4.91MN/AN/AFresh2 Group$1.75M0.52-$14.77MN/AN/A Which has more risk & volatility, ACON or FRES? Aclarion has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Fresh2 Group has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Does the MarketBeat Community believe in ACON or FRES? Aclarion received 2 more outperform votes than Fresh2 Group when rated by MarketBeat users. CompanyUnderperformOutperformAclarionOutperform Votes3100.00% Underperform VotesNo VotesFresh2 GroupOutperform Votes1100.00% Underperform VotesNo Votes Is ACON or FRES more profitable? Fresh2 Group has a net margin of 0.00% compared to Aclarion's net margin of -10,967.15%. Fresh2 Group's return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-10,967.15% -910.84% -218.13% Fresh2 Group N/A N/A N/A Does the media favor ACON or FRES? In the previous week, Aclarion and Aclarion both had 2 articles in the media. Fresh2 Group's average media sentiment score of 1.44 beat Aclarion's score of 0.30 indicating that Fresh2 Group is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Neutral Fresh2 Group Positive SummaryFresh2 Group beats Aclarion on 9 of the 15 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Fresh2 Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FRES and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FRES vs. The Competition Export to ExcelMetricFresh2 GroupMedical laboratories IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$909,000.00$2.84B$16.89B$8.72BDividend YieldN/A1.70%3.66%4.07%P/E RatioN/A10.597.6314.16Price / Sales0.52204.302.7281.71Price / CashN/A382.3712.9836.03Price / Book-0.313.112.215.94Net Income-$14.77M-$32.88M$868.86M$225.73M7 Day Performance-24.06%-5.71%-4.14%-1.34%1 Month Performance-48.99%-4.39%-6.67%1.15%1 Year Performance-91.29%21.23%-4.19%24.02% Fresh2 Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FRESFresh2 GroupN/A$1.01-1.0%N/A-91.4%$910,000.00$1.75M0.0075Short Interest ↓Positive NewsGap DownACONAclarion2.2598 of 5 stars$0.16-5.8%N/A-97.1%$1.66M$53,947.000.007Short Interest ↑News CoverageGap DownMDXHMDxHealth3.4342 of 5 stars$1.64-6.3%N/A-94.7%$0.00$70.19M-1.08300Short Interest ↓Analyst RevisionGap DownHigh Trading VolumeLHLaboratory Co. of America4.7975 of 5 stars$235.21-1.2%N/A+11.6%$19.67B$12.16B45.5067,000Insider SellingNews CoveragePositive NewsHigh Trading VolumeNTRANatera2.8559 of 5 stars$146.06-3.3%N/A+176.6%$19.28B$1.08B-82.993,293Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews CoverageDGXQuest Diagnostics4.9087 of 5 stars$160.44+2.3%N/A+18.9%$17.91B$9.54B21.5648,000Dividend AnnouncementAnalyst RevisionHigh Trading VolumeEXASExact Sciences4.8241 of 5 stars$49.33-3.1%N/A-19.4%$9.13B$2.50B-42.166,600Insider BuyingShort Interest ↓RDNTRadNet3.9475 of 5 stars$79.58-1.8%N/A+151.7%$5.89B$1.77B-1,136.6910,288Gap UpGHGuardant Health4.7375 of 5 stars$29.11-3.6%N/A+30.2%$3.60B$563.95M-6.871,779Short Interest ↓VCYTVeracyte4.5637 of 5 stars$35.94-3.0%N/A+45.4%$2.79B$361.05M-239.60790Analyst ForecastNews CoverageHigh Trading VolumeFTREFortrea3.2974 of 5 stars$19.34-4.3%N/A-40.4%$1.73B$3.11B-5.6518,000Earnings Report Related Companies and Tools Related Companies ACON Alternatives MDXH Alternatives LH Alternatives NTRA Alternatives DGX Alternatives EXAS Alternatives RDNT Alternatives GH Alternatives VCYT Alternatives FTRE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FRES) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh2 Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh2 Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FRES Stock Alerts